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Multidrug resistant bacterial infection remains a significant public
concern. In this report, photosensitizer Chlorin e6 doped silica was
synthesized. This hybrid structure exhibits enhanced photostability
and high antibacterial eﬃciency towards Staphylococcus aureus
(S. aureus) and methicillin-resistant S. aureus (MRSA). In summary,
this work demonstrates an eﬀective platform to improve the eﬃ-
ciency of antibiotics for better treatment of wound infections.
The use of antibiotics advances modern medicine, and it is an
essential tool for almost all medical intervention processes.1
However, despite the continuous development of antibiotics,
bacterial infection remains a significant public concern, parti-
cularly over the past few years, since bacteria are generating
increasing resistance towards the currently available antibiotics,
and the generation of bacterial resistance to antibiotics always
surpasses the development process for new ones.2–7 As a result,
this leads to emerging antibiotic-resistant ‘‘superbugs’’,
which increase the death toll related to bacterial infection.8,9
Among these, multi-drug resistant Gram-positive organisms are
major vital pathogens that cause serious infections, such as
methicillin-resistant Staphylococcus aureus (MRSA). MRSA has
been ranked to be one of the world’s most dangerous bacteria
by the World Health Organization (WHO).10–12
To tackle the issue of bacterial infection, there has been great
eﬀort dedicated to developing new antibiotics. In addition to
researching new antibiotics, nanomaterials have been employed
as tools to significantly increase drug eﬃcacy. For example, silver,
silica, zinc oxide, graphene and polymer nanoparticles have been
utilized to inhibit the growth of bacteria.13–21 These nano-systems
have attractive merits for the treatment of bacterial infection,
namely their ease of surface functionalization, high antibacterial
efficacy and ability to overcome bacterial resistance.22–25 Among
them, mesoporous silica nanoparticles are biodegradable,
leading to excellent biocompatibility and biosafety, and the
convenience of maintaining the release of bio-active molecules
during their degradation.26–28 All of these advantages make silica
nanoparticles a desirable candidate for the delivery of anti-
biotics. Particularly, Song et al. recently reported that silica
nanopollens with surface roughness can load an antimicrobial
enzyme, lysozyme, and achieve significantly enhanced adhesion
to bacteria for long-term bacterial inhibition in comparison
to those with a smooth surface.29 This characteristic further
facilitates the application of silica nanoparticles.
Besides using antibiotics for antimicrobial chemotherapy,
photodynamic therapy (PDT) has also been applied to fight
bacteria.30–32 In PDT, singlet oxygen is generated in the presence of
a photosensitizer and oxygen under light illumination, causing
fatal damage to bacteria.33–36 The application of PDT has been
growing rapidly, because it significantly improves antibacterial
efficacy and can effectively alleviate drug resistance.37 However,
the poor photostability of photosensitizers and low bacterial
affinity hinder their successful applications. Inspired by the suc-
cess of using surface nanostructures for enhanced antimicrobial/
anticancer chemotherapy,29,38,39 we first report a way to synthesize
a silica nanomaterial carrying photosensitizer molecules for a
potent photodynamic therapy to treat Staphylococcus aureus
(S. aureus) andMRSA (Scheme 1). This simple technique is expected
to enhance the stability of the photosensitizer in the silica matrix,
efficiently inhibit bacteria and overcome multi-drug resistance.
Silica nanoparticles are formed using a modified Sto¨ber syn-
thesis solution, followed by treatment at 500 1C for 5 h to remove
a Antibiotics Research and Re-evaluation Key Laboratory of Sichuan Province,
Sichuan Industrial Institute of Antibiotics (SIIA), Chengdu University,
Chengdu, 610052, Sichuan, P. R. China.
E-mail: tony_yan8@hotmail.com, tony.yan@monash.edu
b School of Engineering, Institute for Bioengineering, The University of Edinburgh,
King’s Buildings, Mayfield Road, Edinburgh, EH9 3JL, UK.
E-mail: xianfeng.chen@oxon.org, Michael.Chen@ed.ac.uk
c School of Chemistry, University of Lincoln, Brayford Pool, Lincoln,
Lincolnshire LN6 7TS, UK
d Department of Biomedical Sciences, Faculty of Medicine & Health Sciences,
Macquarie University, Sydney, NSW, 2109, Australia
eMonash Institute of Pharmaceutical Sciences, Monash University, Parkville,
Victoria 3052, Australia
† Electronic supplementary information (ESI) available. See DOI: 10.1039/c9cc00166b
‡ Equal contribution.
Received 8th January 2019,
Accepted 30th January 2019
DOI: 10.1039/c9cc00166b
rsc.li/chemcomm
ChemComm
COMMUNICATION
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 3
1 
Ja
nu
ar
y 
20
19
. D
ow
nl
oa
de
d 
on
 2
/1
2/
20
19
 1
2:
41
:0
2 
PM
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e. View Article Online
View Journal
Chem. Commun. This journal is©The Royal Society of Chemistry 2019
the template surfactant during fabrication. Then, (3-aminopropyl)-
triethoxysilane (APTES) conjugated Chlorin e6 (Ce6) molecules are
incubated with silica nanoparticles, enabling Ce6 loading and
creating a rough surface. Their X-ray diﬀraction (XRD) pattern
indicates that these silica nanoparticles are amorphous (MCM-
Ce6) (Fig. S1A, ESI†). The Fourier Transform Infrared (FT-IR)
spectra of MCM-Ce6 and Ce6 display identical Ce6 peaks,
confirming successful conjugation of Ce6 to silica (Fig. S1B,
ESI†). The loading capacity of Ce6 is approximately 7.8 wt%,
which wasmeasured by absorbance at 400 nm. Themorphology of
MCM-Ce6 was characterized by transmission electron microscopy
(TEM) and scanning electron microscopy (SEM) (Fig. 1A and B).
It can be seen that the diameter of these silica nanoparticles is
approximately 80–150 nm and these nanoparticles have very rough
surfaces.
Next, the optical properties and singlet oxygen generation
capacity of MCM-Ce6 were evaluated (Fig. S2 and S3 ESI†).
As shown in the UV–vis absorption spectrum, it is clear that Ce6
modified silica nanoparticles exhibit very similar absorption
characteristics to free Ce6, further indicating successful con-
jugation of Ce6 to silica nanoparticles (Fig. S2A, ESI†). Subse-
quently, the photostability of MCM-Ce6 was tested and compared
to that of free Ce6 by exposing the materials to 650 nm light for
different time periods (Fig. S2B and S3, ESI†) followed by the
absorbance intensity measurement at 400 nm. The results show
that after 10 minutes of light irradiation, MCM-Ce6 possesses
an absorbance intensity of 70% of the original value; while in
sharp contrast, the absorbance of free Ce6 molecules substantially
drops to below 30%. This observation demonstrates that the
photostability of Ce6 has been significantly improved with covalent
conjugation to silica nanoparticles.
The capacity of singlet oxygen generation by the MCM-Ce6
and free Ce6 molecules was also studied using 1,3-diphenyliso-
benzofuran (DPBF) as a chemical probe. It can be seen that
both materials can eﬀectively generate singlet oxygen (Fig. S2C,
ESI†). This reveals that the process of doping Ce6 molecules
into silica nanoparticles does not induce Ce6 aggregation and
cause decreased capacity of singlet oxygen generation. However,
if both materials are exposed to light for 30 minutes before the
evaluation of their capacity of singlet oxygen generation, the
situation will be diﬀerent. From Fig. S2D (ESI†), it can be seen
that MCM-Ce6 can continuously generate singlet oxygen and
cause the absorbance of DPBF to decrease, while free Ce6
molecules produce a very low amount of singlet oxygen. This
further confirms the enhanced photostability of Ce6 after being
loaded onto silica nanoparticles.
After confirming the improved photostability of MCM-Ce6,
its antibacterial performance was next investigated against
S. aureus and MRSA and the results are presented in Fig. 2 and 3,
respectively. S. aureus is a common naturally occurring and
pathogenic Gram-positive spherical bacterium, while MRSA
is a multi-drug resistant bacterium, which causes intractable
infections in the clinic. Therefore, eﬀective antibacterial agents
to eliminate S. aureus and MRSA are highly desirable. In the
test, the bacteria were cultured with MCM-Ce6 at diﬀerent
concentrations (200, 66.7, 22.2 and 7.4 mg mL1) in the presence
and absence of light illumination. After treatment, the samples
were monitored for turbidity by measuring the optical density
(O.D.) at 600 nm. First, the potential risk of killing the bacteria by
light irradiation alone was investigated. It is apparent that the
light irradiation at our used power intensity did not aﬀect the
growth of S. aureus and MRSA (control +). At a low concentration
of 7.4 mgmL1, MCM-Ce6 has already exhibited excellent bacterial
inhibition for both S. aureus and MRSA upon light irradiation
(Fig. 2D). In comparison, we also studied the antibacterial
Scheme 1 Schematic illustration of Ce6 doped silica nanoparticle fabri-
cation and photo-inspired disinfection.
Fig. 1 Characterization of Ce6 doped silica nanoparticles (MCM-Ce6):
(A) TEM image and (B) SEM image.
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performance of MCM-Ce6 without light irradiation and the
results show dramatically reduced bacterial inhibition eﬃcacy
(Fig. 2A–D). This observation clearly demonstrates the contri-
bution of light excitation. To further evaluate the antibacterial
performance, live/dead analysis of S. aureus was performed
(Fig. 2E). Consistent with O.D. measurements, large amounts of
killed bacteria were found in the light-treated group. Moreover,
the plate countmethodwas carried out after the O.D.measurement.
Similar bacterial inhibition profiles were also observed (Fig. S4 and
S5, ESI†). In addition, the antibacterial performance of MCM-Ce6
was compared with that of traditional Ce6 conjugated silica nano-
particles. The traditional Ce6 conjugated silica nanoparticles were
fabricated by conjugating Ce6molecules with aminemodified silica.
It was found that MCM-Ce6 exhibited an obviously improved
S. aureus inhibition performance compared to traditional Ce6
conjugated silica nanoparticles, particularly after a short exposure
period (Fig. S6, ESI†). Therefore, it is very important to conjugate
APTES and Ce-6 molecules first and then attach them to silica
nanoparticles for enhanced antibacterial performance.
After demonstrating the high eﬃcacy of MCM-Ce6 in anti-
bacterial inhibition in vitro, we moved the application to in vivo
wound healing, utilizing Balb/c mice as a model. A wound was
introduced on their back followed by infection with S. aureus
(Fig. 4). Then the mice were randomly divided into three
groups. Two groups of mice were treated with either free Ce6
molecules or MCM-Ce6. The untreated mice were used as a
control group. During the treatment, a clear diﬀerence in the
wound morphology was observed among the groups and the
representative images are shown in Fig. 4A. Obviously, scabs
were quickly formed in the group of mice treated with
MCM-Ce6 under light irradiation. In contrast, it was diﬃcult
to even form a scab in the group of mice treated with free Ce6
molecules, indicating poor eﬃciency in the in vivo wound
treatment. During the whole treatment period, the mice did
not show any obvious body weight change in all experimental
groups (Fig. 4B). Fig. 4C shows the H&E staining of the
wounded skin harvested from the mice treated with MCM-Ce6,
which indicates a well-organised skin structure and good wound-
healing eﬀect. In addition, H&E staining of the major organs of
themice treated withMCM-Ce6 under light illumination was also
conducted (Fig. S7, ESI†), from which no obvious abnormality
was found, indicating excellent compatibility of Ce6 doped silica
nanoparticles.
In summary, our study illustrates a strategy to synthesize
photosensitizer loaded silica nanoparticles for significantly
enhanced photodynamic therapy to eﬀectively inhibit S. aureus
and MRSA. This drug delivery system improves the photostability
of Ce6 molecules and correspondingly maintains the singlet
oxygen generation capacity under light illumination. When
tested in vivo, the drug delivery system dramatically enhances
wound healing eﬃciency in comparison with fee Ce6 molecules.
Fig. 2 S. aureus inhibition by MCM-Ce6 of diﬀerent concentrations:
(A) 200, (B) 66.7, (C) 22.2 and (D) 7.4 mg mL1. Control means only LB
added. ‘‘ +’’ indicates with light illumination; ‘‘’’ indicates without light
illumination. All data are expressed as mean  s.d. (indicated by an error
bar), based on values obtained from six biological replicates (n = 6).
(E) Live/dead analysis of S. aureus treated with light (light +) or without
light (light ). Scale bars indicate 5 mm.
Fig. 3 Methicillin-resistant S. aureus inhibition by MCM-Ce6 of diﬀerent
concentrations: (A) 200, (B) 66.7, (C) 22.2 and (D). 7.4 mg mL1. Control
means only LB added. ‘‘+’’ indicates with light illumination; ‘‘’’ indicates
without light illumination. All data are expressed as mean  s.d. (indicated
by an error bar), based on values obtained from six biological replicates
(n = 6).
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Also importantly, these Ce6 doped silica nanoparticles have
excellent biocompatibility. This work is the first report on the use
of the nanomaterials’ rough surface for increased performance
in antibacterial photodynamic therapy and demonstrates an
eﬀective platform to improve the eﬃciency of antibiotics.
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